[DPHARMA] YoY TTM Result on 30-Jun-2014 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
26-Aug-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
30-Jun-2014 [#2]
Profit Trend
QoQ- -9.03%
YoY- 7.2%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Revenue 394,690 327,738 197,750 167,697 140,724 140,215 134,988 19.56%
PBT 38,579 46,824 45,813 39,496 39,354 35,468 35,995 1.16%
Tax -3,626 -11,087 -8,393 -7,519 -9,526 -8,043 -6,906 -10.17%
NP 34,953 35,737 37,420 31,977 29,828 27,425 29,089 3.10%
-
NP to SH 35,484 36,314 34,618 31,977 29,828 27,425 29,089 3.36%
-
Tax Rate 9.40% 23.68% 18.32% 19.04% 24.21% 22.68% 19.19% -
Total Cost 359,737 292,001 160,330 135,720 110,896 112,790 105,899 22.58%
-
Net Worth 463,071 510,978 189,815 179,145 187,404 162,310 154,198 20.09%
Dividend
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Div 7,085 8,084 25,710 24,291 20,128 24,980 5,014 5.92%
Div Payout % 19.97% 22.26% 74.27% 75.97% 67.48% 91.09% 17.24% -
Equity
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Net Worth 463,071 510,978 189,815 179,145 187,404 162,310 154,198 20.09%
NOSH 278,959 278,959 139,570 138,872 138,818 138,727 138,917 12.30%
Ratio Analysis
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
NP Margin 8.86% 10.90% 18.92% 19.07% 21.20% 19.56% 21.55% -
ROE 7.66% 7.11% 18.24% 17.85% 15.92% 16.90% 18.86% -
Per Share
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
RPS 141.49 102.62 141.68 120.76 101.37 101.07 97.17 6.45%
EPS 12.72 11.37 24.80 23.03 21.49 19.77 20.94 -7.96%
DPS 2.54 2.53 18.50 17.50 14.50 18.00 3.61 -5.68%
NAPS 1.66 1.60 1.36 1.29 1.35 1.17 1.11 6.93%
Adjusted Per Share Value based on latest NOSH - 138,872
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
RPS 41.03 34.07 20.56 17.43 14.63 14.58 14.03 19.56%
EPS 3.69 3.78 3.60 3.32 3.10 2.85 3.02 3.39%
DPS 0.74 0.84 2.67 2.53 2.09 2.60 0.52 6.05%
NAPS 0.4814 0.5312 0.1973 0.1862 0.1948 0.1687 0.1603 20.09%
Price Multiplier on Financial Quarter End Date
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Date 30/06/17 30/06/16 30/06/15 30/06/14 28/06/13 29/06/12 30/06/11 -
Price 2.25 2.04 2.65 2.97 2.38 2.23 2.34 -
P/RPS 1.59 1.99 1.87 2.46 2.35 2.21 2.41 -6.69%
P/EPS 17.69 17.94 10.68 12.90 11.08 11.28 11.17 7.95%
EY 5.65 5.57 9.36 7.75 9.03 8.87 8.95 -7.37%
DY 1.13 1.24 6.98 5.89 6.09 8.07 1.54 -5.02%
P/NAPS 1.36 1.28 1.95 2.30 1.76 1.91 2.11 -7.05%
Price Multiplier on Announcement Date
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Date 25/08/17 22/08/16 25/08/15 26/08/14 28/08/13 16/08/12 18/08/11 -
Price 2.03 2.14 2.40 3.37 2.44 2.38 2.22 -
P/RPS 1.43 2.09 1.69 2.79 2.41 2.35 2.28 -7.47%
P/EPS 15.96 18.82 9.68 14.64 11.36 12.04 10.60 7.05%
EY 6.27 5.31 10.33 6.83 8.81 8.31 9.43 -6.57%
DY 1.25 1.18 7.71 5.19 5.94 7.56 1.63 -4.32%
P/NAPS 1.22 1.34 1.76 2.61 1.81 2.03 2.00 -7.90%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment